Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Both sides next revision
pharmaceutical_companies:reliance_life_sciences [2023/02/08 08:50]
liam
pharmaceutical_companies:reliance_life_sciences [2024/11/16 19:56] (current)
liam [COVID-19]
Line 10: Line 10:
  
 Reliance is developing a "second-generation" two antigen subunit protein [[:COVID-19 vaccines|COVID-19 vaccine]] called [[:COVID-19 vaccines:RelCoVax]].((Phatarphekar, A., Vidyadhar Reddy, G. E. C., Gokhale, A., Karanam, G., Kuchroo, P., Shinde, K., Masand, G., Pagare, S., Khadpe, N., Pai, S. S., Vijayan, V., Ramnath, R. L., Pratap Reddy, K., Rao, P., Harinarayana Rao, S., & Ramana, V. (2022). //RelCoVax®, a two antigen subunit protein vaccine candidate against SARS-CoV-2 induces strong immune responses in mice.// Vaccine, 40(32), 4522–4530. https://doi.org/10.1016/j.vaccine.2022.06.026)) On September 21, 2021, Dr. [[:Robert Malone]] pitched RelCoVax to an online audience at the [[:Vaccines Summit-2021]].((Housatonic. (2023, February 6). //(Sep 21 2021) Robert malone: “RelCovax, 2ndGen multivalent SARS-CoV-2 vaccine candidate” (Summit).// Rumble. https://web.archive.org/web/20230208073041/https://rumble.com/v28ntb2-sep-21-2021-robert-malone-relcovax-2ndgen-multivalent-sars-cov-2-vaccine-ca.html)) ((//Speakers.// Vaccines Summit-2021. Retrieved April 20, 2021, from https://web.archive.org/web/20210420005033/https://scientiameetings.com/conferences/vaccines/speakers)) Reliance is developing a "second-generation" two antigen subunit protein [[:COVID-19 vaccines|COVID-19 vaccine]] called [[:COVID-19 vaccines:RelCoVax]].((Phatarphekar, A., Vidyadhar Reddy, G. E. C., Gokhale, A., Karanam, G., Kuchroo, P., Shinde, K., Masand, G., Pagare, S., Khadpe, N., Pai, S. S., Vijayan, V., Ramnath, R. L., Pratap Reddy, K., Rao, P., Harinarayana Rao, S., & Ramana, V. (2022). //RelCoVax®, a two antigen subunit protein vaccine candidate against SARS-CoV-2 induces strong immune responses in mice.// Vaccine, 40(32), 4522–4530. https://doi.org/10.1016/j.vaccine.2022.06.026)) On September 21, 2021, Dr. [[:Robert Malone]] pitched RelCoVax to an online audience at the [[:Vaccines Summit-2021]].((Housatonic. (2023, February 6). //(Sep 21 2021) Robert malone: “RelCovax, 2ndGen multivalent SARS-CoV-2 vaccine candidate” (Summit).// Rumble. https://web.archive.org/web/20230208073041/https://rumble.com/v28ntb2-sep-21-2021-robert-malone-relcovax-2ndgen-multivalent-sars-cov-2-vaccine-ca.html)) ((//Speakers.// Vaccines Summit-2021. Retrieved April 20, 2021, from https://web.archive.org/web/20210420005033/https://scientiameetings.com/conferences/vaccines/speakers))
 +
 +===== External links =====
 +
 +  * [[https://wiki.whiteroseintelligence.com/en/Reliance-Life-Sciences|White Rose Wiki]]
Back to top